In this study, the targeting effectiveness of gold nanoparticles conjugated with both antibody types (as well as non-targeted controls) was tested in vitro as well as in vivo in an EGFR-overexpressing mouse tumor model. This evidence concerns the gene EGFR and neoplasm.